PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1128800
PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1128800
The micro invasive glaucoma surgery (MIGS) devices market is projected to register a substantial CAGR of 33.3% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029.
Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market, By Product (MIGS Stents, MIGS Shunts and Others), Target (Trabecular Meshwork Suprachoroidal Space Subconjunctival Filtration and Reducing Aqueous Production), Surgery Type (Glaucoma in Conjunction with Cataract and Stand-Alone Glaucoma), End User (Hospital Outpatient Departments (HOPD), Ophthalmology Clinics, Ambulatory Surgery Centers (ASCS) and Others), Distribution Channel (Direct Tender and Retail Sales), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Switzerland, Netherlands, Belgium, Russia, Turkey and rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and rest of Asia-Pacific, Brazil, Argentina and rest of South America, South Africa, Saudi Arabia, U.A.E., Israel, Egypt and rest of Middle East and Africa) - Industry Trends & Forecast to 2029
Increase in the geriatric population
Rising incidence of glaucoma across the world
Government initiatives to increase awareness about prevention of blindness
AbbVie
BVI
Ellex
Glaukos Corporation
Johnson and Johnson
Alcon
Microsurgical technology
New World Medical
Santen Pharmaceutical
Nova Eye Medical Limited
Belkin Vision
Sight Scientific